Aura Biosciences Inc (AURA)
7.25
+0.22
(+3.13%)
USD |
NASDAQ |
May 28, 16:00
7.25
0.00 (0.00%)
After-Hours: 20:00
Aura Biosciences Market Cap: 359.19M for May 28, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 28, 2024 | 359.19M |
| May 24, 2024 | 348.29M |
| May 23, 2024 | 363.65M |
| May 22, 2024 | 354.73M |
| May 21, 2024 | 344.33M |
| May 20, 2024 | 351.76M |
| May 17, 2024 | 360.18M |
| May 16, 2024 | 356.71M |
| May 15, 2024 | 371.57M |
| May 14, 2024 | 373.06M |
| May 13, 2024 | 355.72M |
| May 10, 2024 | 362.16M |
| May 09, 2024 | 373.56M |
| May 08, 2024 | 366.12M |
| May 07, 2024 | 371.08M |
| May 06, 2024 | 381.48M |
| May 03, 2024 | 390.90M |
| May 02, 2024 | 384.87M |
| May 01, 2024 | 378.93M |
| April 30, 2024 | 366.54M |
| April 29, 2024 | 371.50M |
| April 26, 2024 | 357.63M |
| April 25, 2024 | 350.69M |
| April 24, 2024 | 351.68M |
| April 23, 2024 | 357.63M |
| Date | Value |
|---|---|
| April 22, 2024 | 351.19M |
| April 19, 2024 | 355.94M |
| April 18, 2024 | 349.50M |
| April 17, 2024 | 348.02M |
| April 16, 2024 | 359.40M |
| April 15, 2024 | 373.76M |
| April 12, 2024 | 373.26M |
| April 11, 2024 | 381.18M |
| April 10, 2024 | 377.22M |
| April 09, 2024 | 388.11M |
| April 08, 2024 | 359.40M |
| April 05, 2024 | 356.43M |
| April 04, 2024 | 354.95M |
| April 03, 2024 | 361.38M |
| April 02, 2024 | 366.33M |
| April 01, 2024 | 384.15M |
| March 28, 2024 | 388.61M |
| March 27, 2024 | 381.18M |
| March 26, 2024 | 377.72M |
| March 25, 2024 | 391.08M |
| March 22, 2024 | 416.83M |
| March 21, 2024 | 423.26M |
| March 20, 2024 | 413.86M |
| March 19, 2024 | 369.14M |
| March 18, 2024 | 349.90M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
277.07M
Minimum
Oct 27 2023
707.11M
Maximum
Nov 16 2021
432.11M
Average
414.71M
Median
Jun 30 2022
Market Cap Benchmarks
| Gilead Sciences Inc | 79.63B |
| Regeneron Pharmaceuticals Inc | 107.23B |
| Moderna Inc | 58.71B |
| NovaBay Pharmaceuticals Inc | 5.334M |
| Palatin Technologies Inc | 30.82M |
Market Cap Related Metrics
| Price to Book Value | 1.720 |
| Price | 7.25 |
| Earnings Yield | -25.66% |